Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UPDATE 2-European stocks clock best weekly showing in 2 months, French shares shine

Published 07/06/2019, 17:18
Updated 07/06/2019, 17:18
UPDATE 2-European stocks clock best weekly showing in 2 months, French shares shine

* European shares record best weekly performance in two
months
* Sanofi shares rise after it poaches Novartis
Pharmaceuticals CEO
* Tech stocks rise on hopes of U.S.-China trade thaw

(Recasts, updates to close, adds quote)
By Aaron Saldanha
June 7 (Reuters) - European stocks posted their best weekly
performance since early April on Friday, aided by strong gains
in Paris, against a backdrop of hope among investors that
central banks would support global growth with more
accommodative policies.
The Bundesbank slashed its growth projections for Germany
and euro zone money markets now price in a 60% chance of the
European Central Bank cutting interest rates by 10 basis points
by year-end, while U.S. job growth slowed sharply in May,
feeding expectations of lower U.S. interest rates in 2019.
US/ The pan-European STOXX 600 .STOXX gained 0.9%, with
Paris-traded stocks .FCHI posting a 1.6% gain.
Frankfurt-listed shares .GDAXI rose 0.8%, while their peers in
London .FTSE firmed 1%. .L
"Investors continue to pile into equities, with the jobs
report and subsequent stock rally capping a very good week for
equity markets," Chris Beauchamp, chief market analyst at IG,
wrote in a note.
Sanofi SASY.PA tacked on 4.4% to prop up the French index
and European health care .SXDP stocks, on news it has poached
Paul Hudson from Novartis NOVN.S to become its new chief
executive later this year.
The STOXX 600's top performer was Dutch insurer ASR
Nederland ASRNL.AS with a 5.8% rise, after rival Vivat, for
which ASR previously made an offer, agreed to be bought by
private European life insurer Athora. Technology shares .SX8P , broadly sensitive to trade war
ructions, starred with a 2% gain. Chinese President Xi Jinping
on Friday called U.S. President Donald Trump his friend and said
he believed the United States was not interested in rupturing
economic ties with China. The chemicals sector .SX4P was among Europe's top
performers, rising 1.1%. Belgian chemical and materials maker
Solvay SOLB.BR gained 2.3%, aided by UBS upgrading its rating
on the stock and boosting its target price. While higher Brent crude futures LCOc1 fuelled energy
shares' .SXEP 1.2% rise, Polskie Gornictwo Naftowe i
Gazownictwo SA PGN.WA led the sector with a 3.5% gain. A unit
of the Polish firm bought a stake in the Norwegian King Lear
deposit from Total E&P Norge. O/R
Financial services .SXFP rose 0.8%, with the sector's
gains led by Exor EXOR.MI , which added 1.6%. The Milan-listed
firm is the top shareholder in Fiat Chrysler Automobiles
FCHA.MI , which pulled away from an offer to merge with Renault
RENA.PA earlier this week. Automakers and their suppliers .SX7P gained 0.1%, as a
4.9% fall in German car parts maker Hella HLE.DE following a
rating downgrade by brokerage BHF weighed.
Real estate stocks .SX86P dipped 0.6%, making them the
STOXX 600's only losing sub-sector.
Deutsche Wohnen DWNG.DE slid 8.5% after Morgan Stanley
downgraded its rating on the German property group to "equal
weight" from "overweight". The bank cited the risk of rising political involvement in
the German residential market. The Berlin Senate proposed
earlier this week to impose a five-year rent freeze from January
2020.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.